Grade C · preclinical3 peptides · 47 studies
Glow Stack
No summary filed yet — the Librarian is still assembling this protocol.
This is a description, not a protocol to follow
Everything below is a summary of what people report doing and what the literature contains. Nothing here is medical advice.
What the evidence actually supports
Supported in animals
Animal-model studies indexed · 13
Cell and in-vitro studies indexed · 9
Reviews and uncategorised studies · 17
Not established
Any effect in humans · 8 human studies indexed
Any benefit from combining them · no combination study in our index
Human dose, route or duration · no PK study indexed
Protocol details
The Glow Stack protocol involves three compounds: BPC-157, GHK-Cu, and TB-500. However, published studies have not tested this specific combination of peptides together.
Research on GHK-Cu has primarily focused on its potential applications in wound healing and regenerative medicine. One study demonstrated that a novel wound dressing incorporating GHK-Cu achieved 99.8% wound closure in a mouse model of antibiotic-resistant infection, although its applicability to human wounds remains unestablished [2]. Another review suggested that GHK-Cu shows promise as a regenerative agent in aesthetic medicine, but emphasized the need for more rigorous clinical trials to confirm its efficacy and safety [8]. Additionally, GHK-Cu was shown to extend lifespan and improve aging-related functions in the model organism Caenorhabditis elegans, although its relevance to human aging is not established [23].
BPC-157 has been studied for its protective effects in various contexts. In an animal study, BPC-157 demonstrated protective effects against ischemia-reperfusion injury in rats, reducing oxidative stress and improving muscle architecture [24]. However, no human studies have reported on the effects of BPC-157 in the context of the Glow Stack protocol.
TB-500, or Thymosin Beta-4 Fragment, has not been studied in the context of the Glow Stack either. The available literature includes observational studies that do not directly address the effects of TB-500 in combination with BPC-157 or GHK-Cu [9], [18]. Overall, while individual studies exist for each compound, there is no evidence supporting the efficacy or safety of the Glow Stack as a combined treatment.
Sources
[2] Asymmetric-interfacial nanofibrous membranes with diode-like exudate transport for nanozyme-catalyzed antibacterial wound healing. — Biomaterials, 2026 https://doi.org/10.1016/j.biomaterials.2026.124483
[8] The Regenerative Potential of GHK-Cu in Aesthetic Medicine. — Aesthetic surgery journal, 2026 https://doi.org/10.1093/asj/sjag169
[9] JMB2403, a potential best-in-class PD-1-dependent IL2Rβγ-activating tri-specific antibody for safe and potent immunotherapy. — mAbs, 2026 https://doi.org/10.1080/19420862.2026.2709956
[18] Construction and validation of a prediction model for graft failure in pediatric liver transplant recipients based on the APRI-ALBI score: a retrospective study of 289 cases. — Annals of medicine, 2026 https://doi.org/10.1080/07853890.2026.2654909
[23] The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways. — Biogerontology, 2026 https://doi.org/10.1007/s10522-026-10444-x
[24] Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury. — Scientific reports, 2026 https://doi.org/10.1038/s41598-026-55449-1
Research & studies for this protocol
47 rows · showing 24Newest first
| Study | Compound | Source | Year |
|---|---|---|---|
| This systematic review evaluates the efficacy, safety, and regenerative mechanisms of GHK-Cu in aesthetic medicine. It included 20 studies, with 18 being preclinical and 2 randomized controlled trials (RCTs). The review found that GHK-Cu improved patient-reported satisfaction after laser resurfacing and significantly reduced wrinkle volume and depth compared with controls. | GHK-Cu | europepmc | 2026 |
| Not reported in abstract. | TB-500 (Thymosin Beta-4 Fragment) | PubMed | 2011 |
| Not reported in abstract. | TB-500 (Thymosin Beta-4 Fragment) | PubMed | 2012 |
| This review addresses the design challenges of bioabsorbable flow diverters (FDs) for intracranial aneurysm management. It examines how bioactive materials can balance scaffold resorption with aneurysm occlusion. The paper emphasizes the importance of material properties and design principles in enhancing device functionality. | GHK-Cu | europepmc | 2026 |
| This study investigates the tri-specific antibody JMB2403, designed to activate IL2Rβγ and block PD-1, in various models. The antibody was tested in engineered Jurkat cells and xenograft models for anti-tumor efficacy and immune cell activation. The results indicated a dose-dependent increase in CD8+ T cell proliferation without IL-2-related toxicities. | TB-500 (Thymosin Beta-4 Fragment) | europepmc | 2026 |
| This study developed a biomimetic nanoplatform targeting Alzheimer's disease, integrating multiple therapeutic bioactivities. In APP/PS1 transgenic mice, treatment resulted in reduced Aβ plaque deposition and improved cognitive functions. The study reports various in vitro and in vivo effects without making therapeutic claims. | GHK-Cu | europepmc | 2026 |
| This study measured the effects of systemic administration of tetrathiomolybdate (TTM) on collagen deposition and secretory function in irradiated mouse salivary glands. Mice received TTM in drinking water at a concentration of 0.1 mg/mL starting 7 days before and continuing through 7 days after a single 15-Gy dose of radiation therapy. The results indicated that TTM treatment improved stimulated saliva flow compared to control. | GHK-Cu | europepmc | 2026 |
| This study investigates asymmetric-interfacial Janus nanofibrous membranes for antibacterial wound healing in a murine model. The dressing achieved 99.8% wound closure by day 12 in infected wounds. The study highlights the membrane's ability to reduce bacterial burden and enhance healing without specific therapeutic claims. | GHK-Cu | europepmc | 2026 |
| A 72-year-old man experienced three episodes of cholangitis due to coil migration following treatment for a hepatic artery pseudoaneurysm. The patient underwent transcatheter arterial embolization with tornado microcoils. This case highlights the complications associated with coil migration into the bile duct. | BPC-157 | europepmc | 2023 |
| This study investigates the role of OTUD5 in acute myeloid leukemia (AML) progression by regulating SLC7A11 to suppress ferroptosis. OTUD5 was analyzed in AML patient samples and cell lines, with functional assays conducted following OTUD5 silencing and overexpression. The findings suggest that OTUD5 enhances SLC7A11 stability, promoting AML cell survival. | TB-500 (Thymosin Beta-4 Fragment) | europepmc | 2026 |
| This study investigates the properties of a single layer of Bi2Sr2CuO6+δ (Bi-2201) to understand the effects of dimensionality reduction on superconductivity. The researchers found an approximately 10% reduction in the optimal superconducting transition temperature. The study explores the tunability of the material through controlled oxygenation. | GHK-Cu | PubMed | 2026 |
| Not reported in abstract. | GHK-Cu | PubMed | 2026 |
| A fluorescent aptamer sensor based on a copper-based metal-organic framework was developed to monitor low-density lipoprotein (LDL) levels. The sensor demonstrated a linear range of 0.1-10,000 ng/mL and an ultra-low detection limit of 0.0789 ng/mL. It showed good accuracy and precision in human serum samples. | GHK-Cu | europepmc | 2026 |
| The study evaluated the structural and functional stability of Tachypleus gigas hemocyanin (TgH) across various temperatures and pH conditions. TgH retained 80% phenoloxidase activity up to 70 °C and demonstrated a melting temperature of 77.98 °C. The findings suggest potential applications in therapeutic and biotechnological fields. | GHK-Cu | europepmc | 2026 |
| Not reported in abstract. | GHK-Cu | PubMed | 2026 |
| This study aimed to develop and validate a nomogram based on the APRI-ALBI score for predicting graft failure in pediatric liver transplant recipients. A total of 289 children who underwent primary liver transplantation were analyzed. The nomogram achieved an AUC of 0.706 for graft failure prediction. | TB-500 (Thymosin Beta-4 Fragment) | europepmc | 2026 |
| Not reported in abstract. | GHK-Cu | PubMed | 2026 |
| Not reported in abstract. | GHK-Cu | PubMed | 2026 |
| Not reported in abstract. | GHK-Cu | PubMed | 2026 |
| This study examined the impact of partially substituting inorganic zinc, copper, and manganese with organic forms in diets fed to gestating and lactating sows. A total of 344 sows and gilts were randomized to receive either the organic or inorganic mineral diets. Treated sows showed decreased lactation weight loss and odds of dew claw lesions compared to controls. | GHK-Cu | europepmc | 2026 |
| This paper evaluates the histopathological changes in an endosonographically created route (ESCR) following endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) using a plastic stent in an 83-year-old man with perihilar cholangiocarcinoma. The patient underwent the procedure for recurrent biliary obstruction and died 141 days later, after which an autopsy was performed. The study reports on the fibrotic changes observed at the ESCR site. | BPC-157 | europepmc | 2023 |
| A 59-year-old Filipino man with long-standing unexplained iron-deficiency anemia was diagnosed with <i>Necator americanus</i> infection after gastrointestinal investigations. Image-enhanced endoscopy improved visualization of the parasites, leading to their identification and removal. Treatment with pyrantel pamoate resulted in symptom resolution and improved anemia. | BPC-157 | europepmc | 2023 |
| This study examined the relationship between bowel preparation indicators and colonoscope insertion difficulty in 185 patients undergoing unsedated colonoscopy. The primary focus was on the time to confirmed completion of bowel preparation and its association with cecal intubation time and loop formation. No therapeutic claims are made regarding the findings. | BPC-157 | europepmc | 2023 |
| A 69-year-old woman with uterine leiomyosarcoma developed metachronous metastases including a 15-mm gastric lesion. Endoscopic submucosal dissection was performed, achieving en bloc resection without adverse events. The study highlights the occurrence of incidental gastric metastasis during prolonged disease courses. | BPC-157 | europepmc | 2023 |